A SARC phase II multicenter trial of imatinib mesylate (IM) in patients with aggressive fibromatosis Meeting Abstract
| Authors: | Chugh, R.; Maki, R. G.; Thomas, D. G.; Reinke, D.; Wathen, J. K.; Patel, S.; Priebat, D. A.; Meyers, P. A.; Benjamin, R. S.; Baker, L. H. |
| Abstract Title: | A SARC phase II multicenter trial of imatinib mesylate (IM) in patients with aggressive fibromatosis |
| Meeting Title: | 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 24 |
| Issue: | 18 Suppl. Pt. 1 |
| Meeting Dates: | 2006 Jun 2-6 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2006-06-01 |
| Start Page: | 523S |
| Language: | English |
| ACCESSION: | WOS:000239009403388 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2006.24.18_suppl.9515 |
| Notes: | --- - Meeting Abstract: 9515 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
